NASDAQ$NTRA

Natera Inc · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Natera's Q4 2020 financial results were reported, showing significant revenue growth and increased test processing volume.

Natera reported a 35.1% increase in total revenues for Q4 2020 compared to Q4 2019, driven primarily by product revenue growth. The company also saw a significant increase in the number of tests processed and reported. However, the loss from operations and net loss also increased during the same period.

  • Total revenues increased by 35.1% to $112.4 million compared to Q4 2019.
  • Product revenues grew by 43% compared to the same period last year.
  • Approximately 295,000 tests were processed, including 281,000 tests accessioned in Natera's laboratory.
  • Net loss was $76.4 million, or ($0.89) per diluted share, compared to a net loss of $35.2 million in Q4 2019.

Headline financials

Total Revenue

$112M

Previous: $83.2M+35.1%
EPS (adj)

-$0.89

Previous: -$0.46-93.5%
Tests processed

295.0K

Previous: 209.4K+40.9%
Tests accessioned

281.0K

Previous: 198.3K+41.7%
Tests reported

281.4K

Previous: 200.8K+40.1%
Tests reported (lab)

268.3K

Previous: 189.7K+41.4%
Capital Expenditures

$7.53M

Previous: $2.41M+212.0%
Free Cash Flow

-$80.8M

Previous: -$17.5M-362.7%
Net Income

-$76.4M

Previous: -$35.2M-117.0%
Operating Income

-$74M

Previous: -$34.8M-112.6%
Gross Profit

$52.5M

Previous: $38.8M+35.3%
Cash & Equivalents

$738M

Previous: $441M+67.2%
Total Assets

$932M

Previous: $441M+111.4%
Stock-Based Comp

$15.8M

Previous: $8.52M+85.0%

Revenue & EPS history

Natera · Revenue · Quarterly

$112M

Q4 2020+35.1%vs Q4 2019
Beat estimate in 9 of 16 quarters(56%)
ActualEstimate

Revenue by segment

Natera · $33.9M total across 1 segment · Q1 2021

  • Licensing and other revenues
    $33.9M

Forward guidance

Natera anticipates 2021 total revenue of $500 million to $525 million; 2021 cost of revenues to be approximately 47% to 52% of revenues; selling, general and administrative costs to be approximately $430 million to $450 million; research and development costs to be $160 million to $180 million, and net cash burn to be $230 million to $250 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

+4.4%

Avg return

Earnings day

+4.4%

Avg return

5 days after

+6.0%

Avg return

30 days after

69%

31 / 45 earnings

Positive

+29.1%

Q2 2017

Best reaction

-21.2%

Q3 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.0%-5.2%+0.0%
Q4 2025-3.8%-6.0%-15.5%
Q3 2025+0.7%+5.6%+23.2%
Q1 2025-6.9%-6.9%+0.7%
Q4 2024-0.7%-5.5%-8.1%
Q3 2024+20.2%+9.0%+24.2%
Q2 2024+14.2%+18.6%+12.5%
Q1 2024+10.1%+10.3%+16.2%
Q4 2023+13.6%+18.4%+20.1%
Q3 2023+4.0%+11.2%+33.2%
Q2 2023+16.1%+20.0%+42.3%
Q1 2023-3.6%-3.8%-8.1%
Q4 2022+14.1%+22.2%+14.1%
Q3 2022-13.2%-5.3%-9.2%
Q2 2022+5.1%+3.7%-2.7%
Q1 2022-2.0%-18.5%+0.5%
Q4 2021+10.2%+5.9%-34.7%
Q3 2021+3.6%+1.2%-22.7%
Q2 2021+2.4%-7.7%+8.1%
Q1 2021-2.9%-14.0%-7.1%
Q4 2020+2.9%+4.6%-17.0%
Q3 2020+9.3%+2.3%+16.5%
Q2 2020+11.8%+4.0%+31.2%
Q1 2020+19.8%+28.3%+11.6%
Q4 2019+6.4%+5.6%-27.3%
Q3 2019-3.7%+0.3%-1.3%
Q2 2019+19.3%+9.6%+19.8%
Q1 2019+19.8%+26.8%+34.3%
Q4 2018+19.6%+16.9%+22.9%
Q3 2018-21.2%-25.2%-20.4%
Q2 2018+0.2%+5.2%+8.4%
Q1 2018+1.4%-0.9%+3.6%
Q4 2017+0.3%+17.3%+10.1%
Q3 2017-12.8%-13.4%-11.9%
Q2 2017+29.1%+32.4%+64.0%
Q1 2017+13.8%+11.5%+7.1%
Q4 2016-14.8%-15.9%-10.8%
Q3 2016+12.0%+25.5%+26.8%
Q2 2016-5.8%-17.2%-21.3%
Q1 2016+15.4%
Q1 2014+0.1%
Q4 2015-13.8%
Q3 2014+2.7%
Q3 2015+7.0%
Q2 2014-3.6%
Q1 2015
Q4 2014
Q4 2013
Q3 2013
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro